ZURICH, Oct 10 (Reuters) - Nobel Biocare (NOBN.VX: Quote, Profile, Research, Stock Buzz) shares lost over one third of their value and slumped to a five-year low on Friday, renewing takeover speculation, after the world's No.1 dental implant maker issued another profit warning.
